Abstract. The synthesis of two of the Escherichia coli glycogen biosynthetic enzymes, ADPglucose pyrophosphorylase (glgC) and glycogen synthase (gIgA) was activated by the addition of 5 mM cyclic AMP (cAMP) to maxicells; synthesis of glycogen branching enzyme (glgB) was unaffected./3-Galactosidase activity expressed from a gene fusion, 4~(glgC-lacZ), was approximately five-fold higher in a cya ÷ versus an isogenic cya strain of E. coli. Addition of cAMP restored /3-galactosidase in the cya-strain. The expression of ~b (glgC'-'lacZ) encoded /3-galactosidase activity in a series of spoT mutants exhibited an apparent exponential relationship to intracellular guanosine 5'-diphosphate 3'-diphosphate (ppGpp) levels. These results provide evidence for the control of glycogen biosynthesis in vivo by cAMP and ppGpp at the level of gene expression, and identify a region of DNA required for the control. The qb (glgC'-'lacZ) encoded/3-galactosidase activity was also elevated three-to five-fold in strain AC70RI, which contains a transacting mutation (glgQ) that affects the levels of the glycogen biosynthetic enzymes and glgC transcripts.
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The rate of glycogen biosynthesis in Escherichia coli
is inversely related to nutrient availability and to the growth rate [reviewed in 9] . Thus, a complex of various controls are most likely required to coordinate the synthesis of glycogen to the physiological state of the culture. At least two levels of control are involved. The first step of the biosynthetic pathway is catalyzed by ADP glucose pyrophosphorylase, and a considerable body of information has shown that this step is controlled allosterically in response to intracellular metabolite levels [9] . In addition, the observed variations in the intracellular levels of the three biosynthetic enzymes suggest regulation at the level ofgene expression [9] [10] [11] [12] . Recent studies with coupled transcription-translation assays in S-30 extracts indicated that the expression ofglgC (ADP glucose pyrophosphorylase) and glgA cAMP and ppGpp [15] . The expression of the glgB gene (glycogen branching enzyme) was unaffected by either compound and was proposed to reside in an operon separate from glgC and glgA. In the presence of cAMP receptor protein (CRP), cAMP was also effective in stimulating the expression of glgC and glgA in a compositionally defined assay, which measures the formation of the first dipeptide of specific gene products [ 15, 20] . Although the effects of ppGpp were reproducibly observed with S-30 extracts, no significant effects were observed under the conditions of the dipeptide synthesis assay, and it was suggested that one or more additional factors may mediate the effect [15, 20] .
The present studies were designed to measure the effects of the catabolite repression system and the stringent response system on the expression of the glycogen biosynthetic genes in vivo and to delineate the region of DNA in the glg gene cluster that contains the cis-acting control sites for regulation. The effects of cAMP on glgC, glgA, and glgB were determined in a maxicell expression assay system. The 5'-flanking region of glgC was subcloned into pMLB1034 and /3-galactosidase activity expressed Bacterial strains and media. The strains used in these studies included wild type E. coil B and E. coli B AC70R1 (glgQ) [9] , CF747 (pyrG ÷ recA1 thi-1 pyrE60 argE3 his-4 proA2 thr-1 leuB6 mtl-l xyl-5 ara-14 galK2 lacY1 rpsL31 supE44 cdd gyrA(Nal) relAlh-spoT+), (recA56 srl-3OO::TnlO pyrE + his + pyrG + thi-1 argE3 proA2 thr-1 leuB6 Mtl-I xyl-5 ara-14 galK2 lacY1 rpsL31 supE44 cdd gyrA(Nal) relAlh-spoT202-204) [18] , ML2 (met gal, hsdkR supE supF Km Acya) [3] , and ED8654 (met gal hsdkR supE supF) [3] , MBM7060 (F-araC am araD (argFlac)U169 trp am malB am rpsL relA thi supF (hp 1048)) [19] , HB101 (FphsdS20(rB mB )recA13ara-14proA21acY1 gaIK2 rpsL20(Sm r) xyl-5 mtl-I supE44h ) [6] , MCL22 (trkA405 trkDl thi A( kdp-phr )214 rha 8( gal-uvrB ) A( srl-rec A )306 rps L31) [5] . The preparation of Kornberg medium [ 15] and MOPS minimal medium [18] was previously described. The M9 minimal medium contained 0.6% Na2HPO 4, 0.3% KH2PO4, 0.5% NaCI, and 0.15% NHaCI. M9-supplemented medium is M9 minimal medium plus 1 mM MgSo 4, 0.1 mM CaCI 2, 2 /zg biotin ml, 1 ktg thiamine ml, 0.4% casamino acids, and 0.5% glucose. M9 sulfate-free medium was M9-supplemented medium with the substitution of MgC12 for MgSO 4 and without casamino acids.
Plasmids. The plasmid pMLB1034 was previously described [19] . Plasmid pOP12 contains the E. coli glycogen biosynthetic genes cloned into pBR322 [8] . Plasmid pOP189 is an EcoRl-generated derivative of pOPI2 that lacks the glgC and glgA genes [8] . The plasmid pCZ3 was constructed by ligating a 0.7 KbHincll-BamHl restriction fragment from pOP12 into the SmaI-BamHl site of pMLB1034, and transforming HB101 to ampicillin resistance. The plasmid pCZ3 was characterized by restriction endonuclease mapping and contained an out-of-frame fusion of the glgC and lacZ genes. A previously described in vivo method for isolating in-frame mutations of plasmid-encoded lacZ gene fusions [19] was used to obtain several such plasmids. These were characterized by restriction mapping. The plasmid chosen for study, pCZ3-3, resulted from an 8-bp deletion event which removed the single BamHI site in pCZ3. Codon 64 of glgC is fused to codon 9 oflacZ in pCZ3-3 (T. Romeo and J. Preiss, unpublished nucleotide sequence data). The procedures utilized in plasmid construction were previously described [15, 16] .
Maxicell analysis. The maxicell procedure was used for identification of plasmid-encoded proteins [17] , with minor modifications suggested by Dr. M. C. Lorence (University of Texas Health Science Center at Dallas). Exponential cultures from MCL22, which had been transformed with the plasmids of interest, were grown to an absorbance of 0.60 at 450 nm in M9-supplemented medium containing tetracycline (20/~g/ml), irradiated with shortwave UV light, and mixed with an equal volume of M9-supplemented medium. Cultures were incubated at 37°C for 3 h and treated with cycloserine (200/~g/ml). Cultures were incubated an additional 3 h and treated again with cycloserine. After overnight incubation, the cultures were treated a third time with cycloserine, washed and resuspended in sulfate-free M9 medium, and incubated for 1 h. The cultures were then split into two 2.5-ml portions, and cAMP (5 mM) was added to one of the portions. The cultures were incubated for 10 min and were labeled with [35S]methionine (5/~Ci/ml) for 1 h. Cells were washed with M9 minimal medium, suspended in lysis buffer (0.125 M Tris, pH 6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol), and heated for 2 min at 100°C. Equal volumes of cell proteins (20/~L from 100 /zL of cell extract) were analyzed in 10% SDS polyacrylamide slab gels with the buffer system of Laemmli [4] . The gels were stained with Coomassie blue, and labeled proteins were visualized by fluorography, as described [15] .
fl-galactosidase assays. Assays were carried out according to Miller [7] with minor modification. Bacterial cultures were grown in either MOPS minimal medium or Kornberg medium containing 0.2% glucose and 100 p.g/ml ampicillin at 37°C with gyratory shaking at 200 rpm. For enzyme assays, 0.125 ml of culture was added to 0.5 ml of 0.1 M sodium phosphate buffer, pH 7.0,containing 0.2 M KCI, 0.002 M MgSO 4, 0.1 M 2-mercaptoethanol, and 100/~g/ml chloramphenicol. This was followed by addition of 0.25 ml of 300/.Lg/ml sodium deoxycholate and one drop of toluene. The reactions were shaken at 37°C for 30 min, cooled to room temperature, and 0.25 ml of 13.3 mM o-nitrophenyl /3-D-galactopyranoside (ONPG) or water (for no substrate blanks) was added. The enzymatic reactions were allowed to proceed for 10 min at 22°C and were stopped by the addition of I N K2CO 3. The reactions were subjected to centrifugation to eliminate turbidity, and absorbance of each reaction was determined at 420 nm, relative to an identical blank reaction that lacked ONPG. In order to correct for differences in cell mass of the cultures during these experiments, the enzyme activity (A420) was normalized relative to cell mass (A6o~). In order to calculate/3-galactosidase expressed from 4~(glgC'-lacZ), the uninduced expression from the chromosomal copy of lacZ was estimated by measuring /3-galactosidase activity from strains containing pMLVI034 and was subtracted from the activity from pCZ3-3-containing strains. Although the large number of samples required for these studies prohibited the determination of more than a single experimental value for each time point, each of the growth curve experiments has been conducted at least twice, with similar results. to examine the effect of exogenous cAMP on the in viva expression of the glycogen biosynthetic genes. Figure 1 shows that several plasmid-encoded proteins were synthesized in strain MCL22[pOP12] but not in MCL22[pBR322]. The overall pattern was similar to that of the proteins expressed in vitro from pOP12 [16] . The three largest labeled proteins were identical in electrophoretic mobility with purified standards of ADPglucose pyrophosphorylase (49 kDa), glycogen synthase (52 kDa), and glycogen branching enzyme (84 kDa Values are expressed as fl-galactosidase activity/cell mass (A420/A600).
Results

Effects of cAMP on the expression of gig genes in maxicells. The maxicell technique was used in order
pMLB 1034 and pCZ3-3, and/3-galactosidase activity was measured in both transformants. Table 1 shows that (i) no /3-galactosidase activity was expressed from pMLB1034, which lacks the glgC DNA; (ii) the expression of/3-galactosidase from pCZ3-3 is not affected by IPTG, the gratuitous inducer of the native lacZ gene; and (iii) pCZ3-3-encoded activity is elevated in stationary phase, as would be expected if the expression of/3-galactosidase is under glgC regulatory control.
In order to examine the effect of cAMP on glgC expression, isogenic strains ED8654 (cya +) and ML2 (Acya) were transformed with pCZ3-3,and pCZ3-3-encoded/3-galactosidase activity was determined throughout the growth curve. Figure 3 shows that the growth rate of these strains was essentially identical under the conditions shown; however, the synthesis of plasmid-encoded /3-galactosidase was approximately fivefold higher in ED8654 than in ML2 throughout the growth curve. The addition of 5mM cAMP to the cultures resulted in a stimulation of the synthesis of plasmid-encoded/3-galactosidase activity in ML2 almost to the level observed in ED8654 and resulted in an increase of activity of approximately 50% in ED8654. The growth rate of each strain was decreased to a similar extent in the presence of exogenous cAMP.
The effect of ppGpp on expression of the glgC'-lacZ gene was assessed by a series of spoT mutants which were impaired to various extents in their ability to degrade endogenous ppGpp [18] . The elevated intracellular levels of ppGpp in these strains result in a decrease in their growth rates. The doubling times and ppGpp levels for these strains were previously shown to exhibit a linear relationship [18] . Figure 4 shows the quantitative relationship between plasmid-encoded /3-galactosidase activity and growth rate of these strains. Maximal activity in these strains occurred during the early-to midexponential phase, then decreased until the cultures entered the stationary phase. Therefore, the activity Insets a and b of Fig. 4 compare the doubling times for these strains with the plasmid-encoded/3-galactosidase activity. Since the intracellular ppGpp concentrations vary in a direct linear relationship with the doubling times under the growth conditions used in these experiments [18] , these results establish that an exponential relationship exists between intracellular ppGpp in these strains and the expression of 4~(glgC'-lacZ). Although the copy numbers of pCZ3-3 in spoT strains were not measured, the effects of these spoT mutations on the copy number of a similar pBR322-derived plasmid were minimal [18] .
A trans-acting mutation, glgQ, leads to increases in the levels of the three glycogen biosynthetic enzymes (approximately tenfold for ADP glucose pyrophosphorylase and fivefold for glycogen synthase [9] ) and was recently shown to affect transcription ofglgC [15] . The strain containing the glgQ mutation, E. coli B AC70R1, and wild type E. coli B were transformed with plasmid pCZ3-3 or pMLB 1034, and the resulting/3-galactosidase activity was determined. Table 2 shows that under the higher in AC70R1 [ Table 2 ]. Figure 5 compares the pattern of 4)(glgC'-'lacZ) expression through the growth curves of these strains. These results suggest that the glgQ mutation does not affect the regulatory factors responsible for the expression of the native lacZ gene, i.e. cAMP, CRP,or ppGpp. However,the gtgQ mutation has a significant effect upon the expression of 4)(glgC'-'lacZ).
conditions used for the growth, both E. coli B [pBML 1034] and AC70R 1 [pMLB 1034] synthesized similar levels of/3-galactosidase. This indicated that the glgQ mutation in AC70RI did not alter expression of the chromosomal lacZ gene. Additional experiments to compare the expression of the chromosomal lacZ gene in E. coli B and AC70R1 did not alter expression of the chromosomal lacZ gene. Additional experiments to compare the expression of the chromosomal lacZ gene in E. coli B and AC70RI were carried out in minimal medium in the presence or absence of IPTG (6.25 mM) and glucose (0.5%). The/3-galactosidase activity from these two strains differed by no more than 35% under any condition tested (data not shown). In contrast, the expression of d)(glgC'-lacZ) of pCZ3-3 was two-to fivefold
Discussion
Previous in vitro studies on the expression of genes for glycogen biosynthesis indicated that cAMP and ppGpp may function to positively alter the level of expression ofglgC and glgA [ 15] . Evidence for regulation in the case of cAMP was particularly strong and included the observations that cAMP activated the expression of transcription-translation reactions and, in the compositionally defined dipeptide synthesis assay, that the cAMP-CRP complex was capable of binding specifically to restriction fragments from the region proximal to glgC [15] . However, evidence that ppGpp activates the expression of glg genes was less definitive. In particular, ppGpp did not enhance glgC expression in the dipeptide assay [15, 20] . The results of the present study support the ch(glgC'-'lacZ) exhibited a peak in the midexponential phase in spoT strains. This peak of activity is likely to reflect fluctuation of the basal ppGPp concentration in these strains, although intracellular levels of ppGPp in these strains have been measured only during the midexponential phase [18] . The second surprising trend in the spoT strains was the apparent exponential relationship between ppGpp levels and the expression of 6(glgC '-lacZ) . This relationship appears to be the inverse of that observed for the activity of the rrnA P1 promoter in these strains, which showed an inverse exponential relationship to the doubling times and to ppGpp levels [18] . The precise explanation for these exponential responses awaits rigorous biochemical understanding of the mechanism of ppGpp in these systems. There is mounting evidence that ppGpp may play an important role in general growth rate regulation in addition to its well-established involvement in stringent response [I, 2, and references therein]. This is consistent with the observation that glycogen biosynthesis varies according to the growth rate of the culture [9] and offers a potential mechanism for the regulation. These studies have further defined the properties of the glycogen excess mutant AC70RI, which was recently shown to positively affect transcription of glgC [16] . It appears that the expression of chromosome-encoded lacZ is not significantly altered in AC70RI. Therefore, glgQ probably does not reside in either the catabolite repression or the stringent response regulatory systems, which regulate the expression of native lacZ [15, 16] . This suggests that a third independent regulatory system controls gig gene expression.
On the basis of the limited amount of gig DNA that was used in constructing ch(glgC'-'lacZ), cisacting sites required for cAMP, ppGpp, and glgQ effects are now known to reside within 0.5 Kb of the glgC transitional start site. Previous studies mapped 5' termini of four discrete transcripts within this region [15] . It is now of interest to determine which of these transcripts respond to cAMP and/or ppGpp.
The transcript proximal to the glgC coding region was present in high levels in AC70R1 (25-fold higher than in E. coli B). However, the site of the glgQ mutation and the nature of the factor(s) altered by this mutation are not known, presenting an important challenge for further investigation.
